SPI NewsUnited States · Dispensing and closures packaging
Aptar Q3 2026 results: Closures sales rose 11% as a $58 million Russia loss cut diluted EPS to $0.51
Aptar’s third-quarter net sales rose 6% to $1,019.1 million and Closures sales 11%, but adjusted EPS fell to $1.52 from $1.62; Aptar guides fourth-quarter adjusted EPS to $1.39 to $1.47, and the quarter ends on 31 December.
Key takeaways
- Aptar’s release of 29 October reports Q3 2026 net sales of $1,019.1 million, up 6% from $961.1 million, with core sales up 5% and growth in Pharma, Beauty and Closures.
- Diluted EPS fell to $0.51 from $1.92 after Aptar deconsolidated its Russian subsidiary, which a government decree placed under external administration; the release puts the after-tax impact at $0.94 per diluted share.
- Closures’ reported and core sales both rose 11%, to $207.8 million, on bottled water, concentrates, a beverage dispensing closure and condiments, while its adjusted EBITDA margin fell 60 basis points to 15.5%, the filing shows.
- Aptar guides fourth-quarter adjusted EPS to $1.39 to $1.47, assuming a 17.5% to 19.5% tax rate and EUR/USD at 1.12, and raised its quarterly dividend to $0.50 from $0.48.
- SPI analysis: Closures added $19.8 million of sales but only $1.8 million of adjusted EBITDA, an incremental margin of about 9.3% by SPI’s calculation, which is what cost pass-through looks like in a supplier’s accounts.
$1,019.1m
Q3 2026 net sales
Up 6% from $961.1m; core sales up 5%
Aptar release, 29 Oct 2026
1.52
Q3 2026 adjusted EPS
$ a share, against $1.62 at comparable exchange rates; diluted EPS $0.51 against $1.92
Aptar release, 29 Oct 2026
11%
Q3 2026 Closures sales growth
Reported and core; segment sales $207.8m against $188.0m
Aptar release, 29 Oct 2026
Source: Aptar, Q3 2026 results release and Form 8-K Exhibit 99.1, 29 Oct 2026 (SPI summary), checked 22 Nov 2026.
The Aptar Q3 2026 results, released on 29 October, show net sales up 6% to $1,019.1 million and core sales up 5%, with all three segments growing. Diluted EPS fell to $0.51 from $1.92 after a $61.2 million pre-tax charge from deconsolidating the company’s Russian subsidiary, while adjusted EPS was $1.52 against $1.62 a year earlier.
Aptar, the Crystal Lake, Illinois maker of drug delivery devices, beauty dispensers and closures, reported in its results release that Closures sales rose 11% on strong demand for bottled water, concentrates and condiments. Its adjusted EBITDA margin fell to 21.3% from 23.2%, and margins fell in every segment, even as sales rose in each one1.
For a buyer of caps, pumps and dispensers, the quarter carries one message: Aptar is passing higher input costs through to customers in Beauty and Closures, and the release says that pass-through diluted the Closures margin. By SPI’s reading, brands negotiating 2027 closure and dispensing contracts should expect those cost lines to stay in the price, at a supplier whose beverage closure lines are running on strong demand.
How Aptar's three segments reach packaging buyers
Aptar reports three segments, and each sells a different kind of component. Pharma supplies drug delivery systems and components for nasal, pulmonary, eye care, dermal and injectable therapies, the areas its release names. Beauty supplies dispensing systems for prestige fragrance, colour cosmetics and hair care. Closures supplies caps and dispensing closures for beverages, food and condiments, the product category that the EU tethered caps rule covers for drinks containers.
The segments differ sharply in size and margin. In the third quarter Pharma accounted for about 44.5% of net sales, Beauty 35.1% and Closures 20.4%, by SPI’s calculation from the segment table in the Form 8-K exhibit2. Pharma earned about 69.4% of segment adjusted EBITDA before corporate costs, because its margin of 36.4% is more than twice that of the other two.
That mix explains why the group’s earnings move mainly with Pharma, while packaging buyers feel Beauty and Closures most. Closures is the smallest segment by sales, yet it carries the beverage, food and condiment business that sits closest to brand owners’ bill of materials. The release names input-cost pass-through in both Beauty and Closures, and not in Pharma.
Aptar states segment performance through two measures. Reported sales growth includes currency and the effect of acquisitions or deconsolidations, while core sales growth strips those out. In Closures both were 11%, so the growth was organic, as the release states in a single line.
“Closures’ reported sales rose 11% from the prior year period, with core sales growth of 11%.”
For a closures buyer, that figure measures demand and price together, because pass-through of higher input costs counts in core sales. The release does not split the 11% between volume and price, so SPI has not yet confirmed how much of it came from more units shipped.
What the Aptar Q3 2026 results show by segment
Group sales. Net sales were $1,019.1 million against $961.1 million, a 6% rise, with core sales up 5%, according to the release published at 5:00 PM on 29 October1. The Russian subsidiary’s net sales are excluded from core sales in both periods, the filing says.
Group profit. Adjusted EBITDA was $217.2 million against $222.6 million, a margin of 21.3% against 23.2%. Operating income was $135.0 million against $136.9 million, and adjusted EBIT $141.7 million against $147.4 million. Net income attributable to AptarGroup fell to $32.6 million from $127.9 million2.
Earnings per share. Diluted EPS was $0.51 against $1.92. Adjusted EPS was $1.52, which the release compares with $1.62 for the prior-year period, including comparable exchange rates. That is a fall of about 6.2%, by SPI’s calculation.
Russia. Aptar deconsolidated its Russian subsidiary in the quarter after what the filing describes as a governmental decree placing the subsidiary under external administration and the resulting loss of control. The loss on deconsolidation was $58.0 million, including about $30.0 million of cash held by the subsidiary. With about $2.6 million of receivable reserves and $0.5 million of legal costs, the pre-tax impact was $61.2 million and the after-tax impact $60.4 million, or $0.94 per diluted share2. The release gives no date for the decree.
Tax. The reported effective tax rate was 45.6%, which the filing links to the non-deductible tax impact of the Russian deconsolidation. The adjusted rate was 23.4%.
Outlook. Aptar guides fourth-quarter adjusted EPS to $1.39 to $1.47, assuming an effective tax rate of 17.5% to 19.5% and a euro to dollar rate of 1.12. The reconciliation table in the filing assumes about 65.8 million diluted shares and shows $1.22 for the fourth quarter of 20252.
The President and CEO, new in the role, opened the release’s commentary on the quarter with the top line.
“We delivered broad-based revenue growth across all three segments.”
Pharma. Reported sales rose 2% and core sales 1%, or 8% excluding emergency medicine destocking. The filing names central nervous system and pulmonary therapies, nasal decongestants, eye care and dermal drug delivery, plus demand tied to biologics, vaccines and GLP-1 therapies. The adjusted EBITDA margin fell 80 basis points to 36.4%, which the release attributes to short-term unfavourable mix from destocking, while royalties and productivity improvements helped.
Beauty. Reported sales rose 9% and core sales 8%, on demand for prestige fragrance dispensing, colour cosmetics and hair care. Pass-throughs of higher input costs also contributed. The adjusted EBITDA margin fell 70 basis points to 11.4%, on unfavourable mix and what the release calls ongoing challenges in North American operations2.
Closures. Reported and core sales rose 11%. The filing says beverage and food sales grew significantly, led by bottled water and concentrates, continued momentum from the latest beverage dispensing closure innovation and strong condiment sales. Pass-throughs of higher input costs contributed positively to core sales growth, but the release says their dilutive impact drove the 60 basis point margin decline to 15.5%.
Aptar's segment results line by line
The segment table in the filing gives dollar figures that the release text states only as percentages. Closures sales rose to $207.8 million from $188.0 million, a gain of $19.8 million, while Closures adjusted EBITDA rose to $32.2 million from $30.3 million, a gain of $1.8 million on the filing’s unrounded figures2.
SPI calculation (where the pass-through shows): Closures turned $19.8 million of extra sales into $1.8 million of extra adjusted EBITDA, an incremental margin of about 9.3%, below the segment’s 15.5% margin. Beauty turned $29.6 million of extra sales into $1.0 million, about 3.2%. Pharma’s sales rose $8.6 million while its adjusted EBITDA fell $0.6 million. All three use the filing’s figures in thousands.
Corporate costs moved the other way. Corporate and Other adjusted EBITDA was minus $20.8 million against minus $13.3 million, a swing of about $7.6 million, by SPI’s calculation. Segment adjusted EBITDA rose to $238.0 million from $235.8 million, so the fall in group adjusted EBITDA came from the corporate line, not from the segments in total.
Over nine months, Closures grew more slowly and earned less. Its sales rose about 7.4% to $589.3 million from $548.7 million, while adjusted EBITDA fell about 4.2% to $85.7 million from $89.5 million, and the margin to about 14.5% from 16.3%, by SPI’s calculation from the filing. Beauty’s nine-month sales rose about 12.4%, and Pharma’s about 4.1%, with Pharma’s adjusted EBITDA flat at $465.3 million.
Group nine-month net sales were $3.03 billion, up 8%, with core sales up 2%. Diluted EPS for January to September was $3.00 against $4.75, and adjusted EPS $4.13 against $4.601.
| Line item | Q3 2026 | Q3 2025 | Change | 9M 2026 | 9M 2025 |
|---|---|---|---|---|---|
| Pharma net sales | 454.0 | 445.4 | 1.9% | 1,350.7 | 1,297.5 |
| Pharma adjusted EBITDA | 165.1 | 165.8 | -0.4% | 465.3 | 465.1 |
| Beauty net sales | 357.4 | 327.8 | 9.0% | 1,088.5 | 968.3 |
| Beauty adjusted EBITDA | 40.7 | 39.7 | 2.4% | 125.9 | 124.0 |
| Closures net sales | 207.8 | 188.0 | 10.5% | 589.3 | 548.7 |
| Closures adjusted EBITDA | 32.2 | 30.3 | 6.1% | 85.7 | 89.5 |
| Group net sales | 1,019.1 | 961.1 | 6.0% | 3,028.5 | 2,814.4 |
| Group adjusted EBITDA | 217.2 | 222.6 | -2.4% | 618.7 | 624.3 |
Source: Aptar, Form 8-K Exhibit 99.1; changes and margins by SPI's calculation except where reported (SPI summary), checked 22 Nov 2026.
USD millions except margins. Segment figures as reported by Aptar; the release rounds Closures growth to 11%. Changes are calculated from the filing's figures in thousands. Adjusted EBITDA is non-GAAP. Segment adjusted EBITDA excludes Corporate and Other, which was minus 20.8 in Q3 2026 and minus 13.3 in Q3 2025.
Cash and returns. Operating cash flow for nine months was $389.8 million against $386.3 million, and capital expenditure $192.0 million against $183.6 million, leaving free cash flow of $197.8 million against $206.0 million2. Aptar bought back about 234,000 shares for $30 million in the quarter and returned $61 million in total, and $272 million so far in 2026.
Dividend. The quarterly dividend rises to $0.50 from $0.48, about 4.2% by SPI’s calculation, payable on 3 December 2026 to holders of record on 12 November 2026, according to the release.
| Item | Q3 2026 | Q3 2025 |
|---|---|---|
| Diluted EPS | $0.51 | $1.92 |
| Adjusted EPS | $1.52 | $1.62 |
| Loss on deconsolidation of Russian subsidiary | $58.0m | no data |
| Total pre-tax impact of the deconsolidation | $61.2m | no data |
| After-tax impact per diluted share | $0.94 | no data |
| Reported effective tax rate | 45.6% | 17.1% |
| Adjusted effective tax rate | 23.4% | 20.8% |
Source: Aptar, Form 8-K Exhibit 99.1, 29 Oct 2026 (SPI summary), checked 22 Nov 2026.
USD. Figures as reported by Aptar. Adjusted EPS is non-GAAP; the release states the prior-year adjusted figure including comparable exchange rates. Restructuring charges were about $2.2 million in both quarters.
Industry reaction
“Closures continues its great momentum, with innovation helping drive increased demand, particularly for our beverage technologies.”
The sentence in the release matches the segment table, where Closures was the fastest-growing segment at 11% reported growth.
“We expect Aptar to finish the year strong, supported by continued Pharma growth, particularly in consumer healthcare and injectables and without the headwind from emergency medicine destocking.”
Aptar’s fourth-quarter guide of $1.39 to $1.47 compares with adjusted EPS of $1.22 a year earlier, shown in the filing’s reconciliation table, a rise of about 14% to 20% by SPI’s calculation2.
“In Beauty, we remain focused on improving our long-term North American trajectory, while we continue to see pockets of healthy demand in areas, such as prestige fragrance, globally.”
The Beauty margin of 11.4% was the lowest of the three segments, and the release ties part of its fall to North American operations.
Silgan, the US maker of dispensers and closures that reported the same day, described a different quarter in its closures business. Its results release says Dispensing and Specialty Closures volumes were comparable with a year earlier, as softer demand for food and beverage closures in Europe and North America offset growth in fragrance and pharma dispensing3.
SPI has not yet confirmed what Aptar’s management said on its conference call at 8:00 a.m. Central Time on 30 October, or whether analysts asked about closure pricing for 2027. No customer, trade body or regulator has commented publicly on the results in a source SPI has read.
Who gains and who pays as Aptar passes on costs
Aptar Closures. The segment won volume and price in the quarter, with sales up 11% to $207.8 million. Its margin fell to 15.5%, and the release says the dilution came from passing higher input costs through to customers, which keeps the dollar profit rising while the percentage falls.
Beverage brands buying closures. Bottled water and concentrates led the Closures growth, the filing says. Brands in these categories are paying for higher input costs through pass-through, and they compete with each other for capacity on the beverage dispensing closure lines that Aptar says are in demand.
Food and condiment brands. The filing names strong condiment sales as a driver. Squeeze-bottle and flip-top cap buyers face the same pass-through mechanism as beverage brands. Food-contact closures also fall under the EU PFAS limits that have applied since 12 August 2026, under SPI Regulation Tracker record PR-EU-0026.
Fragrance and beauty brands. Beauty sales rose 9% to $357.4 million, with prestige fragrance dispensing named first. Beauty buyers pay pass-through too, and Aptar’s margin of 11.4% leaves it little room to absorb further cost increases, by SPI’s reading of the filing.
Pharma customers. Emergency medicine destocking cut Pharma’s core growth to 1% from 8%. That is a drug delivery device item rather than a packaging one, and the CEO’s outlook expects the rest of the year without that headwind.
Aptar shareholders. They bore the Russia loss of $0.94 a share but receive a higher dividend of $0.50 a quarter, and Aptar returned $272 million to them in the first nine months.
Water brands named in SPI’s database. The SPI Buyers Database records that Danone’s evian and Volvic bottles already use 100% recycled PET and that their caps fall under the tethering rule of PR-EU-015; Nestlé Waters’ bottles carry the same rule10. These are exposure notes, not Aptar customer claims.
| Company, segment or buyer | Exposure | Q3 2026 figure | Q3 2025 figure | Source |
|---|---|---|---|---|
| Aptar Closures | Beverage, food and condiment closures | Net sales 207.8 | Net sales 188.0 | Aptar filing |
| Aptar Beauty | Fragrance, cosmetics and hair care dispensers | Net sales 357.4 | Net sales 327.8 | Aptar filing |
| Aptar Pharma | Drug delivery devices | Adjusted EBITDA 165.1 | Adjusted EBITDA 165.8 | Aptar filing |
| Silgan Dispensing and Specialty Closures | Dispensers, pharma devices, food and beverage closures | Adjusted EBIT 111.2 | Adjusted EBIT 113.5 | Silgan release |
| Danone (evian, Volvic) | Tethered caps under PR-EU-015 | 100% rPET bottles | no data | SPI Buyers Database |
| Nestlé Waters | Tethered caps and recycled content under PR-EU-015 and PR-EU-016 | No figure | no data | SPI Buyers Database |
Source: Aptar, Form 8-K Exhibit 99.1, 29 Oct 2026; Silgan release, 29 Oct 2026; SPI Buyers Database, checked 13 Oct 2026.
USD millions as reported. Rows measure different things (sales, adjusted EBITDA, adjusted EBIT) and are not added up or ranked. The Danone and Nestlé rows are exposure notes from SPI's database, not Aptar or Silgan customer claims.
The pinch point: pass-through that dilutes margin
The quarter’s numbers show a supplier with strong demand that earns a lower percentage on it. Closures sales rose 10.5% in dollars while segment adjusted EBITDA rose about 6.1%, by SPI’s calculation, and the release says the dilution came from pass-through of higher input costs2.
Pass-through is a contract mechanism: when resin, metal or other inputs cost more, the supplier raises its price by the cost increase rather than by a margin on it. Dollar profit is protected, but the margin falls, because sales rise faster than profit. The release does not name the inputs, does not mention resin and gives no volume figure for Closures.
That leaves buyers without the number they most need: how much of the 11% was price. A brand whose cap prices rose in the quarter cannot tell from the filing whether its supplier shipped more units or simply billed more for the same units. SPI has not yet confirmed the split.
The nine-month figures show the effect is not new to the third quarter. Closures’ adjusted EBITDA margin for January to September was about 14.5%, against 16.3% a year earlier, by SPI’s calculation from the filing, while segment sales rose about 7.4%. A supplier whose nine-month margin fell while sales grew has a reason to hold firm on pass-through terms in 2027 talks.
Tariffs are absent from the segment commentary. They appear only in the filing’s list of forward-looking risks, and the release does not quantify any tariff cost. The fourth-quarter guide assumes EUR/USD at 1.12, so a move in the euro would change Aptar’s reported dollar results.
SPI analysis
Silgan’s release, published the same day, says its Dispensing and Specialty Closures segment absorbed a delayed pass-through of manufacturing cost inflation. Two US closure suppliers both report pass-through as a margin issue, which suggests buyers should expect cost recovery to continue into 2027 contracts rather than ease.
How Aptar compares with Silgan, Sonoco and Huhtamaki
Four packaging groups that SPI has covered reported their third quarters between 21 and 29 October. Aptar, Silgan and Sonoco report in US dollars; Huhtamaki reports in euros, so its figures are shown only as growth rates and are not compared in amount.
Silgan’s Dispensing and Specialty Closures net sales rose 1% to $699.2 million from $690.4 million, which its release attributes to pass-through of higher raw material and other costs, partly offset by mix and currency3. Adjusted EBIT fell 2% to $111.2 million, and SPI covered the full report in its Silgan story.
Sonoco’s net sales fell 4.2% to $2,042 million, as SPI’s Sonoco story reported, with weather cutting metal can volumes. Huhtamaki’s net sales rose 5% with comparable growth of 4%, and its Flexible Packaging comparable sales rose 18%, with higher raw material prices passed on, according to SPI’s Huhtamaki story15.
By SPI’s reading, the common thread is pass-through. Aptar, Silgan and Huhtamaki all describe higher input costs moving into customer prices in the quarter. What differs is demand: Aptar’s closures grew 11% on beverage and food demand, while Silgan reports softer food and beverage closure demand in Europe and North America.
| Company or segment | Currency | Q3 2026 sales growth | Profit line | Pass-through named |
|---|---|---|---|---|
| Aptar Closures | USD | 11% reported, 11% core | Adjusted EBITDA margin 15.5% (16.1%) | Yes, dilutive to margin |
| Aptar group | USD | 6% reported, 5% core | Adjusted EBITDA margin 21.3% (23.2%) | Yes, in Beauty and Closures |
| Silgan Dispensing and Specialty Closures | USD | 1% | Adjusted EBIT down 2% | Yes, delayed for manufacturing inflation |
| Sonoco group | USD | -4.2% | Adjusted EPS $1.67 ($1.92) | Not covered here |
| Huhtamaki group | EUR | 5% reported, 4% comparable | Not compared | Yes, in Flexible Packaging |
Source: Aptar release, 29 Oct 2026; Silgan release, 29 Oct 2026; SPI Sonoco and Huhtamaki stories, checked 22 Nov 2026.
Growth rates as reported. Segment scopes and profit measures differ (adjusted EBITDA for Aptar, adjusted EBIT for Silgan, adjusted EPS for Sonoco). Huhtamaki reports in EUR and is shown by growth rate only. Figures are not comparable, summed, averaged or ranked across companies or currencies.
Which SPI-tracked rules bear on each Aptar segment
None of Aptar’s reported figures is driven by a regulation in the release, but EU rules set the design of the closures and dispensers its customers buy. SPI matched each segment’s products against records in the SPI Regulation Tracker.
Tethered caps. Since 3 July 2024, beverage containers of up to three litres with plastic caps or lids may be placed on the EU market only if the caps stay attached during use, under Article 6(1) of the Single-Use Plastics Directive and record PR-EU-0154. A closure that conforms to EN 17665:2022+A1:2023 is presumed to comply. Glass and metal containers with plastic caps are outside the rule.
Recycled content in bottles. PET bottles must contain at least 25% recycled plastic from 2025, and all covered beverage bottles at least 30% from 2030, as a Member State average, under record PR-EU-0165. The record notes that under the 2026 counting method tethered caps count in the plastic weight, so a heavier virgin cap lowers the bottle’s recycled share unless the cap also contains recycled plastic.
PFAS in food contact. From 12 August 2026, food-contact packaging may not contain PFAS at or above 25 ppb for any single PFAS, 250 ppb for the sum of PFAS, both by targeted analysis, or 50 ppm for total PFAS, under record PR-EU-0026. The limits bind food-contact packaging of every material, which by SPI’s reading includes closures that touch food or drink.
Recyclability. The PPWR expects all packaging to be recyclable, with design-for-recycling grades from 2030, under record PR-EU-0107. Multi-material pumps and dispensers face harder design questions than mono-material caps, as SPI’s Ledger piece on PPWR recyclability grades explains.
| Aptar segment | Q3 2026 share of net sales | SPI-tracked EU rules | Key date | What it means for the buyer |
|---|---|---|---|---|
| Closures | 20.4% | PR-EU-015, PR-EU-016, PR-EU-002, PR-EU-010 | 3 Jul 2024 (tethered caps); 1 Jan 2030 (30% recycled bottles) | Cap weight and recycled content now affect the bottle's recycled share |
| Beauty | 35.1% | PR-EU-001, PR-EU-010 | 12 Aug 2026 (PPWR applies); 2030 (recyclability grades) | Multi-material pumps need a recyclability plan |
| Pharma | 44.5% | PR-EU-001 | 12 Aug 2026 (PPWR applies) | Medicinal packaging treatment not yet confirmed by SPI |
Source: SPI Regulation Tracker records PR-EU-001, PR-EU-002, PR-EU-010, PR-EU-015 and PR-EU-016, data as of 14 Oct 2026; Aptar release, 29 Oct 2026 (SPI summary), checked 14 Oct 2026.
SPI analysis. The mapping matches each segment's products as described by Aptar with SPI Regulation Tracker records; it is not an Aptar disclosure and not legal advice. How the PPWR treats medicinal packaging is not yet confirmed by SPI.
SPI analysis
About a fifth of Aptar’s third-quarter sales, by SPI’s calculation, sit in the segment most exposed to EU packaging design law. For beverage brands, the closure is no longer a minor part of the pack: under PR-EU-016 its weight counts in the recycled-content average from which Member States report.
What it means for you
SPI analysis
These points follow from the sources above. They are not investment or legal advice; check with counsel on EU and US packaging obligations.
- Beverage brands: Aptar says bottled water and concentrates led Closures growth of 11%. Lock 2027 volumes for tethered and dispensing caps early, and ask suppliers to show volume and price separately in any pass-through request.
- Procurement teams: Aptar and Silgan both describe input-cost pass-through. Check which index or cost basket your closure contracts follow, and how quickly a fall in inputs passes back to you.
- Food and condiment brands: confirm PFAS test data for food-contact closures and liners against the limits in force since 12 August 2026; SPI’s PFAS Ledger piece sets out the values.
- Packaging engineers: cap weight now counts in the recycled share of a bottle under PR-EU-016. Test lighter or recycled-content tethered caps; SPI’s tethered caps Ledger piece covers the rule.
- Beauty brands: Aptar’s Beauty margin of 11.4% leaves little room to absorb costs. Plan for pass-through and start recyclability work on multi-material pumps before the 2030 grades apply.
- Supplier risk teams: Aptar’s Russia deconsolidation shows how quickly a subsidiary can leave a supplier’s control. Map second sources for closures and dispensers using the SPI Buyers Database.
Track PR-EU-015 and PR-EU-016 in the SPI Regulation Tracker, and US state rules in the United States tracker.
- past
- next
- European Union
- EU tethered caps rule applies (PR-EU-015)past
- PPWR applies, with PFAS limits for food contact (PR-EU-002)past
- Aptar Q3 2026 results: sales up 6%, adjusted EPS $1.52past
- Aptar Q3 conference callpast
- Record date for Aptar's $0.50 dividendnext
- Aptar dividend payablenext
- Q4 ends; Aptar guides adjusted EPS of $1.39 to $1.47next
- PPWR: harmonised material-composition sorting label (PR-EU-003)European Union
- PPWR: 90% separate collection of beverage containers (deposit systems) (PR-EU-007)European Union
- 30% recycled content for covered beverage bottles (PR-EU-016)next
- PPWR: 2030 minimum recycled content in plastic packaging (PR-EU-004)European Union
- PPWR: 2030 reuse targets for transport and grouped packaging (PR-EU-006)European Union
- PPWR: restrictions on certain single-use packaging formats (PR-EU-008)European Union
- PPWR: maximum 50% empty space in grouped, transport and e-commerce packaging (PR-EU-009)European Union
- PPWR: all packaging recyclable by 2030 (PR-EU-010)European Union
- Commission review of the PPWR PFAS restrictionnext
Source: Aptar release, 29 Oct 2026; SPI Regulation Tracker, checked 14 Oct 2026.
Show the data
| Date | Label | Category | Link |
|---|---|---|---|
| 2024-07-03 | EU tethered caps rule applies (PR-EU-015) | past | /data/packaging-regulation-tracker/european-union/pr-eu-015/ |
| 2026-08-12 | PPWR applies, with PFAS limits for food contact (PR-EU-002) | past | /data/packaging-regulation-tracker/european-union/pr-eu-002/ |
| 2026-10-29 | Aptar Q3 2026 results: sales up 6%, adjusted EPS $1.52 | past | https://finviz.com/news/412253/aptar-reports-third-quarter-2026-results |
| 2026-10-30 | Aptar Q3 conference call | past | https://finviz.com/news/412253/aptar-reports-third-quarter-2026-results |
| 2026-11-12 | Record date for Aptar's $0.50 dividend | next | https://finviz.com/news/412253/aptar-reports-third-quarter-2026-results |
| 2026-12-03 | Aptar dividend payable | next | https://finviz.com/news/412253/aptar-reports-third-quarter-2026-results |
| 2026-12-31 | Q4 ends; Aptar guides adjusted EPS of $1.39 to $1.47 | next | https://finviz.com/news/412253/aptar-reports-third-quarter-2026-results |
| 2030-01-01 | 30% recycled content for covered beverage bottles (PR-EU-016) | next | /data/packaging-regulation-tracker/european-union/pr-eu-016/ |
| 2030-02-12 | Commission review of the PPWR PFAS restriction | next | /data/packaging-regulation-tracker/european-union/pr-eu-002/ |
| 2028-08-12 | PPWR: harmonised material-composition sorting label (PR-EU-003) | European Union | https://www.strategicpackaginginsights.com/data/packaging-regulation-tracker/european-union/pr-eu-003/ |
| 2029-01-01 | PPWR: 90% separate collection of beverage containers (deposit systems) (PR-EU-007) | European Union | https://www.strategicpackaginginsights.com/data/packaging-regulation-tracker/european-union/pr-eu-007/ |
| 2030-01-01 | PPWR: 2030 minimum recycled content in plastic packaging (PR-EU-004) | European Union | https://www.strategicpackaginginsights.com/data/packaging-regulation-tracker/european-union/pr-eu-004/ |
| 2030-01-01 | PPWR: 2030 reuse targets for transport and grouped packaging (PR-EU-006) | European Union | https://www.strategicpackaginginsights.com/data/packaging-regulation-tracker/european-union/pr-eu-006/ |
| 2030-01-01 | PPWR: restrictions on certain single-use packaging formats (PR-EU-008) | European Union | https://www.strategicpackaginginsights.com/data/packaging-regulation-tracker/european-union/pr-eu-008/ |
| 2030-01-01 | PPWR: maximum 50% empty space in grouped, transport and e-commerce packaging (PR-EU-009) | European Union | https://www.strategicpackaginginsights.com/data/packaging-regulation-tracker/european-union/pr-eu-009/ |
| 2030-01-01 | PPWR: all packaging recyclable by 2030 (PR-EU-010) | European Union | https://www.strategicpackaginginsights.com/data/packaging-regulation-tracker/european-union/pr-eu-010/ |
What to watch next
- 12 Nov 2026: record date for Aptar’s raised quarterly dividend of $0.50 a share.
- 3 Dec 2026: the dividend is payable.
- 31 Dec 2026: Aptar’s fourth quarter ends, with adjusted EPS guided to $1.39 to $1.47 at a tax rate of 17.5% to 19.5% and EUR/USD of 1.12.
- Q1 2027: by SPI’s reading, the start of 2027 closure and dispenser contract rounds, where pass-through terms show whether cost recovery continues.
- 1 Jan 2030: covered beverage bottles must average at least 30% recycled plastic under PR-EU-016, with caps counted in the weight.
- 12 Feb 2030: the Commission reviews the PPWR PFAS restriction under PR-EU-002.
- No date confirmed by SPI: Aptar’s fourth-quarter results date, and any update on its former Russian subsidiary.
FAQ
What were Aptar's Q3 2026 results?
Aptar reported third-quarter 2026 net sales of $1,019.1 million, up 6% from $961.1 million, with core sales up 5%. Diluted EPS was $0.51 against $1.92, after the Russian deconsolidation, and adjusted EPS $1.52 against $1.62. The adjusted EBITDA margin fell to 21.3% from 23.2%, according to the 29 October release.
How did Aptar's Closures segment perform in Q3 2026?
Closures’ reported and core sales both rose 11%, to $207.8 million from $188.0 million, on bottled water, concentrates, a beverage dispensing closure and condiments. Adjusted EBITDA rose to $32.2 million, but the margin fell 60 basis points to 15.5%, which Aptar attributes to the dilutive effect of passing higher input costs through to customers.
Why did Aptar's diluted EPS fall in Q3 2026?
Aptar deconsolidated its Russian subsidiary after a government decree placed it under external administration. The loss on deconsolidation was $58.0 million and the total pre-tax impact $61.2 million, or $0.94 per diluted share after tax. Diluted EPS fell to $0.51 from $1.92, while adjusted EPS, which excludes the item, was $1.52.
What is Aptar's Q4 2026 guidance?
Aptar expects fourth-quarter 2026 adjusted EPS of $1.39 to $1.47, assuming an effective tax rate of 17.5% to 19.5% and a euro to dollar rate of 1.12. That compares with adjusted EPS of $1.22 in the fourth quarter of 2025, a rise of about 14% to 20%, by SPI’s calculation.
Did Aptar raise its dividend?
Yes. Aptar raised its quarterly dividend to $0.50 a share from $0.48, an increase of about 4.2% by SPI’s calculation. It is payable on 3 December 2026 to shareholders of record on 12 November 2026. Aptar also bought back about 234,000 shares for $30 million in the third quarter.
Sources
- Aptar via Business Wire, Aptar Reports Third Quarter 2026 Results, 29 October 2026 (consulted 2026-11-03)
- AptarGroup, Inc., Form 8-K, Exhibit 99.1: Aptar Reports Third Quarter 2026 Results, filing copy with tables, 29 October 2026 (consulted 2026-11-03)
- Silgan Holdings Inc., Silgan Announces Third Quarter 2026 Results; Raises Full Year Earnings Estimate Midpoint (PDF), 29 October 2026 (consulted 2026-11-03)
- SPI Regulation Tracker, PR-EU-015: Single-Use Plastics Directive tethered caps and lids, record data as of 14 October 2026 (consulted 2026-11-03)
- SPI Regulation Tracker, PR-EU-016: SUP Directive recycled content in plastic beverage bottles, record data as of 14 October 2026 (consulted 2026-11-03)
- SPI Regulation Tracker, PR-EU-002: PPWR PFAS limits in food-contact packaging, record data as of 14 October 2026 (consulted 2026-11-03)
- SPI Regulation Tracker, PR-EU-010: PPWR all packaging recyclable by 2030, record data as of 14 October 2026 (consulted 2026-11-03)
- SPI Regulation Tracker, PR-EU-001: EU Packaging and Packaging Waste Regulation (PPWR) applies, record data as of 14 October 2026 (consulted 2026-11-03)
- SPI Regulation Tracker, United States packaging regulation tracker, data as of 14 October 2026 (consulted 2026-11-03)
- SPI, SPI Packaging Buyers Database, Danone and Nestlé profiles, data as of 14 October 2026 (consulted 2026-11-03)
- SPI Ledger, Tethered caps two years on: what Nestlé and Tesco report under the Single-Use Plastics Directive, 29 October 2026 (consulted 2026-11-03)
- SPI Ledger, PFAS in food-contact packaging from 12 August 2026: the limit values and what they mean for paper and board, 30 October 2026 (consulted 2026-11-03)
- SPI Ledger, PPWR recyclability grades: how the A, B and C design-for-recycling classes will work, 30 October 2026 (consulted 2026-11-03)
- SPI, Silgan Q3 2026 results: record adjusted EPS of $1.31 as Metal Containers volumes fell 4%, 2 November 2026 (consulted 2026-11-03)
- SPI, Huhtamaki Q3 2026 results: adjusted EBIT rose 10% on a EUR 23m one-off as North America’s margin fell to 4.3%, 1 November 2026 (consulted 2026-11-03)
- SPI, Sonoco took an $829 million goodwill impairment and cut its 2026 outlook as weather hit food can volumes, 25 October 2026 (consulted 2026-11-03)